Differences in viral kinetics between genotypes 1 and 3 of hepatitis C virus and between cirrhotic and non-cirrhotic patients during antiviral therapy.
about
Is pegylated interferon superior to interferon, with ribavarin, in chronic hepatitis C genotypes 2/3?Evaluation of Versant Hepatitis C Virus Genotype Assay (LiPA) 2.0A mathematical model of hepatitis C virus dynamics in patients with high baseline viral loads or advanced liver disease.Very early prediction of response to HCV treatment with PEG-IFN-alfa-2a and ribavirin in HIV/HCV-coinfected patientsSofosbuvir-based therapy for patients with chronic hepatitis C: Early experience of its efficacy and safety in KoreaHepatitis C Viral Kinetics in Special PopulationsA pharmacokinetic-viral kinetic model describes the effect of alisporivir as monotherapy or in combination with peg-IFN on hepatitis C virologic response.Hepatitis C virus RNA kinetics: drug efficacy and the rate of HCV-infected cells loss.Early and accurate prediction of Peg-IFNs/ribavirin therapy outcome in the individual patient with chronic hepatitis C by modeling the dynamics of the infected cells.The impact of fibrosis and steatosis on early viral kinetics in HCV genotype 1-infected patients treated with Peg-IFN-alfa-2a and ribavirin.Hepatitis C treatment response kinetics and impact of baseline predictors.Pegylated interferon alfa and ribavirin for 14 versus 24 weeks in patients with hepatitis C virus genotype 2 or 3 and rapid virological response.
P2860
Q24644729-EB064969-6F5A-4859-A70B-FC423B7CACBEQ27486402-C425819B-21E9-4843-A1CA-ABB27FCCE9A0Q33906899-DEFF5E7E-26C2-451C-915A-F65CB0B3A057Q34788754-982434EC-D70D-4749-A512-61F18408E32BQ36460249-979E1F2D-11D0-4503-A80A-B501DD6B0359Q37060801-466B6EC4-7B03-4FC8-BEF8-63214E10BDEBQ42196934-19749A9E-CD66-4BD5-9A21-EBFA81AE99C4Q42909353-36E66232-4EB9-44CA-92B7-C1F290386B16Q42977551-DA112FF0-FD4E-4543-8FBC-74DD7161CB44Q42981009-82BC37BE-92DC-4231-8786-391C8B8805F8Q42997280-975EEE3D-264C-489C-81EB-8A3A5830396EQ43041800-678FBAEC-9B2C-4214-BCD5-F873193F4813
P2860
Differences in viral kinetics between genotypes 1 and 3 of hepatitis C virus and between cirrhotic and non-cirrhotic patients during antiviral therapy.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Differences in viral kinetics ...... ents during antiviral therapy.
@en
Differences in viral kinetics ...... ents during antiviral therapy.
@nl
type
label
Differences in viral kinetics ...... ents during antiviral therapy.
@en
Differences in viral kinetics ...... ents during antiviral therapy.
@nl
prefLabel
Differences in viral kinetics ...... ents during antiviral therapy.
@en
Differences in viral kinetics ...... ents during antiviral therapy.
@nl
P2093
P2860
P356
P1476
Differences in viral kinetics ...... ents during antiviral therapy.
@en
P2093
Avidan-U Neumann
Fernanda de Mello Malta
Flair-Jose Carrilho
Isabel-Maria-Vicente-Guedes de Carvalho Mello
Joao-Renato-Rebello Pinho
Jose-Eymard Medeiros-Filho
Luiz-Caetano da Silva
P2860
P304
P356
10.3748/WJG.V12.I45.7271
P407
P577
2006-12-01T00:00:00Z